Medscape Medical News
- Alert Dabigatran Recalled Over Potential Carcinogen
- Alert FDA Strengthens Mammography Regulations: Final Rule
- Alert FDA Declines Approval for Omecamtiv Mecarbil in HFrEF
- Alert Lilly Cuts Insulin Price by 70%, Caps Out-of-Pocket Cost
- Alert FDA Warns of Potential Problems With Abbott Trifecta Valves
- Alert Lupin Recalls Quinapril Tablets Due to Potential Carcinogen
- Alert FDA Calls for Withdrawal of Multiple Myeloma Drug Pepaxto
- Alert FDA Issues Updated Safety Alert on Endologix AAA Repair Grafts
- Alert FDA Expands List of Getinge IABP System and Component Shortages
- Alert Another Recall Related to Medtronic HVAD System
- Alert Blenrep for Multiple Myeloma Withdrawn From US Market
- Alert Serious Recall of Intera Oncology's Hepatic Artery Infusion Pump
- Alert Medtronic Recalls Additional Faulty HeartWare HVAD Batteries
- Alert Class I Recall of Medtronic Cobalt, Crome Cardiac Devices
- Alert Irritable Bowel Syndrome Therapy Removed From Market (Again)
- Alert FDA Warns of Increased Risk of Death With CLL, Lymphoma Drug
- Alert White House Expands Access to Monkeypox Vaccines
- Alert FDA Class I Recall: Batteries for CARESCAPE 2860 Ventilator
- Alert FDA Volara Ventilator Warning Upgraded to Full Recall
- Alert Class I Recall for Medtronic's HeartWare HVAD Batteries